Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Cancer Epidemiol. 2014 Sep 5;38(5):599–607. doi: 10.1016/j.canep.2014.08.005

Red meat and fruit intake is prognostic among patients with localized cutaneous melanomas more than 1 mm thick

Bonnie E Gould Rothberg a,b,c,d, Kaleigh J Bulloch a, Judith A Fine e, Raymond L Barnhill f, Marianne Berwick g,h
PMCID: PMC4229370  NIHMSID: NIHMS626298  PMID: 25194935

Abstract

Background

As the 10-year mortality for localized cutaneous melanoma more than 1.00 mm thick approaches 40% following complete resection, non-therapeutic interventions that can supplement recommended active surveillance are needed. Although guidelines recommending nutrition, physical activity and tobacco cessation for cancer survivors have been published, data describing their associations with melanoma survivorship are lacking.

Methods

Analysis of modifiable lifestyle behaviors collected on the 249 cases with melanomas more than 1.00 mm thick enrolled in the Connecticut Case-Control Study of Skin Self-Examination study was conducted. Independent associations with melanoma-specific survival were evaluated through Cox proportional hazards modeling adjusting for age, gender, Breslow thickness, ulceration and the presence of microsatellites. Independently significant variables were then combined into a single model and backwards elimination was employed until all remaining variables were significant at p<0.05.

Results

Following adjustment for age, Breslow thickness and anatomic site of the index melanoma, daily fruit consumption was associated with improved melanoma-specific survival (HR=0.54; 95% CI: 0.34–0.86) whereas at least weekly red meat consumption was associated with worse outcomes (HR=1.84; 95% CI: 1.02–3.30). Natural red (HR=0.44; 95% CI: 0.22–0.88) or blond (HR=0.52; 95% CI: 0.29–0.94) hair were also favorably prognostic. Higher fish consumption was of borderline significance for improved survival only when considered independently (HR=0.65; 95% CI: 0.40–1.05); no association was seen following adjustment for red meat and fruit consumption (p>0.10).

Conclusions

Dietary choices at the time of diagnosis are associated with melanoma-specific survival in patients with melanomas more than 1.00 mm thick. Further validation of our findings in larger cohorts with repeated post-diagnostic measures is warranted to further evaluate whether dietary modification during the survivorship period can improve melanoma-specific survival.

Keywords: Cutaneous Melanoma, Prognosis, Mortality, Red meat, Fruit, Hair color, Alcohol use, Fish, Smoking, Body mass index

1. Introduction

The 10-year mortality for localized cutaneous melanomas >1.00 mm thick is 30–60% following curative intent resection [1]. Yet, due to the morbidity associated with approved interferon-based adjuvant therapy, active surveillance is the recommended standard-of-care for the majority of these patients with active treatments commencing only after metastatic disease is confirmed [2]. Consequently, “fear of recurrence”, a spectrum of symptoms that range from mild depression and irritability to debilitating anxiety manifested during the follow-up period [3], is highly prevalent among melanoma survivors [46].

Heightened fear of recurrence can convert the cancer diagnosis into a teachable moment for promoting lifestyle behaviors with potential prognostic benefit [7]. Lifestyle interventions display a survival benefit across multiple malignancies. For example, smoking cessation improves outcomes in lung [8, 9] and oropharyngeal cancers [9, 10], abstinence from alcohol improves head and neck cancer survival [11] and regulation of energy balance through weight management and/or physical activity has a positive prognostic influence on most hormonally-regulated and gastrointestinal cancers [1215].

Nonetheless, the study of modifiable lifestyle factors with respect to melanoma prognosis is still sparse and has largely been restricted towards describing patterns of post-diagnosis ultraviolet light (UV) exposure and the associated risk of developing second primary melanomas [6, 1619]. Even fewer published studies describe the association between modifiable lifestyle factors and recurrence of the index melanoma. Two large cohort studies, the US-based Cancer Prevention Study II (CPS-II) and the British Million Women Study, have evaluated the effects of body mass index (BMI) captured at the time of diagnosis on melanoma-specific survival and both studies reported a null association [20, 21]. The CPS-II also considered cigarette smoking. Cigarette smoking was assessed only at the time of enrollment prior to any cancer diagnosis and showed fewer accrued deaths due to melanoma after 24 years of follow-up among those who smoked at the time of enrollment compared with never-smokers [22]. However, absence of a dose-response relationship across pack-years smoked weakens their evidence for causation. By contrast, the Roswell Park Cancer Institute hospital-based cohort study reported a null association between cigarette smoking, captured as a single measurement at the time of diagnosis, and melanoma-specific survival [9]. To the best of our knowledge, neither alcohol nor dietary preferences have been evaluated in the context of melanoma prognosis.

Here, we evaluate the association between lifestyle factors using a single measurement taken at diagnosis and melanoma specific survival for patients from the Connecticut Skin Self-Examination Case Control Study (1987–1989) with melanomas >1.00 mm thick. Significant associations can identify the set of lifestyle choices with potential relevance to melanoma outcomes suitable for further analysis, including longitudinal assessment in survival cohorts, with the goal of identifying those with prognostic potential in the setting of active surveillance.

2. Methods

2.1. Study Population

The Connecticut Skin Self-Examination Case-Control Study (1987–1989) was initially conducted among Caucasian Connecticut residents to evaluate the association between skin self-examination and melanoma mortality. Study design and recruitment strategies, approved by the Yale Human Investigations Committee to comply with the principles embodied in the Declaration of Helsinki, have been previously described elsewhere [23, 24]. Briefly, cases included Connecticut residents diagnosed with localized cutaneous malignant melanoma during January 15, 1987, and May 15, 1989, and were identified through the Connecticut Tumor Registry Rapid Case Ascertainment System. Following primary physician approval, eligible participants were contacted by trained nurse-interviewers to obtain informed consent. 650 cases were enrolled, representing 75% of all potentially eligible individuals.

2.2. Assessment of Demographic and Lifestyle Variables

Demographic and lifestyle variables were assessed by self-report at time of enrollment through a structured interview administered in-person by a trained nurse-interviewer. Height (inches) and weight (pounds) were captured as continuous variables with participants stating their current height and weight at 1-year prior to the interview. Hair color, defined as natural (uncolored or bleached) color at age 20, was categorized into eight levels: blonde, dishwater blonde, light brown, medium brown, reddish-blonde, red-brown, dark brown, or black. Hair samples were provided to aid participant selections. Eye color was selected from eight choices guided by colored pictorials: blue, blue-gray, gray, green, blue-green, hazel, medium-brown, or dark-brown. Tobacco use was evaluated by first defining lifetime ever-smokers as any participant who smoked at least one cigarette per day for 3 or more months. Then, among ever smokers, current smoking status, average packs/day, age at initiation and, if relevant, at quitting were collected. Alcohol consumption was captured as a 5-level variable with available categories: no consumption, less than 1 drink/week, 1–5 drinks/week, 1–2 drinks/day, 3–4 drinks/day and more than 5 drinks/day. Dietary preference for red meat, fish, green salad, and fruit at the time of the interview were assessed as a 4-level scale with categories for daily, greater than once/week, once per week or less or no consumption. Regular use of vitamin/mineral supplements was coded as yes, no or occasional. Marital status groupings included married, widowed, currently separated, currently divorced and never married. Highest educational level attained was described as less than seventh grade, junior high school, partial high school, high school graduate, partial college, Bachelor’s degree and Graduate degree.

2.3. Assessment of Pathologic Variables

For each case, the hematoxylin and eosin-stained slides of the index melanoma were re-annotated by a single dermatopathologist (RLB). Breslow thickness (millimeters), Clark level of invasion (I–V) and mitotic index (number of mitoses/high-powered field), were recorded as continuous variables. Ulceration, regression, microsatellites and solar elastosis were each coded as binary variables noting the presence or absence of each. Histologic subtype was classified as superficial spreading, nodular, lentigo malignant melanoma and other. Degree of tumor-infiltrating lymphocytes (TIL) was noted as absent, non-brisk or brisk. Anatomic site was captured from the original surgical report, corroborated with the patient interview and grouped according to head and neck, upper limb, lower limb and trunk [25]. If assessment of a parameter was not possible from the provided slides, then values recorded on the diagnostic hospital pathology report were used, if available.

2.4. Follow-up and Vital Status Ascertainment

Participants and their referring physicians were re-contacted biannually by mail and/or telephone through 2004. Ascertainment of death was through the Connecticut Tumor Registry and Connecticut Department of Public Health State Vital Records Office. Cause of death was determined from the Death Certificate. The median follow-up was 16 years with 80% followed for more than 5 years and 67% followed for 10 or more years.

2.5. Data Analysis

T stage according to the AJCC 7th Edition criteria [1] was determined for all participants using Breslow thickness, ulceration status and, where necessary, mitotic index. Breslow thickness was categorized according to T stage cutpoints (1.00 or less, 1.01–2.00 and 2.01–4.00 and more than 4.00) and mitotic index was reclassified as 0, 1–6 and more than 6 mitoses/high-powered field. Age at diagnosis was dichtomized, dividing individuals as 65 years or younger versus more than 65 years at diagnosis. BMI was calculated from the reported height and weight as [(weight/2.2)/(height*0.0254)]2 and categorized according to NHANES cutpoints for obese (BMI of 30.0 or more), overweight (BMI of 25.0–29.9) and normal/underweight (BMI less than 25.0) [26]. Tobacco use captured both smoking status at the time of diagnosis (never, former and current) and, among ever-smokers, total pack-years smoked to yield a 5-level variable describing never smokers, and two categories each for former and current smokers based on having smoked less than or more than 20 pack-years at the time of diagnosis. Alcohol consumption was grouped semi-quantitatively as never-drinkers, less than 1 drink/week, 1–5 drinks/week and 1 drink a day or more. Dietary covariates were dichotomized as ‘weekly or more’ or ‘less than weekly’ except for fruit consumption which was dichotomized as daily versus less than daily. Vitamin use was dichotomized into never- and ever- users. Hair, eye color, marital status and education categories were also simplified. Hair color was reduced to three categories: blondes and dishwater blondes were included as blonde, reddish-blonde and red-brown were grouped as red and the remaining four levels combined as brunette/black. Eye color was dichotomized with individuals reporting dark or light brown eyes included as brown/black and those individuals reporting hazel, blue, green or grey eyes grouped as blue/green. Education levels were grouped as less than high school, high school diploma, some college, Bachelor’s degree and Graduate degree. Marital status was simplified by combining ‘currently separated’ and ‘currently divorced’ into a single category. For all variables, missing values were not imputed and individuals with a missing value were censored from analyses where variables for which missingness occurred were included.

Univariate distributions for each demographic, pathologic and lifestyle variable were obtained and bivariate associations with Breslow thickness were calculated using a chi-square analysis. Univariate and multivariate survival analyses for lifestyle variables, the latter adjusting for established clinicopathologic prognostic factors, were performed using the Cox Proportional Hazards regression with hazard ratios (HRs) and 95% confidence intervals (95% CIs) reported. Overall P-values for proportional hazards models were calculated using the likelihood ratio test. All statistical analyses were performed using SAS version 9.3 or statistical platform (SAS Institute, Cary, NC).

3. Results

Among the 650 cases included in the parent study, re-staging according the AJCC 7th edition criteria [1] was possible for 577 individuals of which 113 (19.6%) died of melanoma during the follow-up period. Because of the high (94%) melanoma-specific survival among T1 melanomas, this study is limited to the subset of 249 individuals with melanomas more than 1.00 mm thick who accrued 92 (83.2%) of the observed melanoma-specific deaths. Bivariate associations between the demographic, pathologic and lifestyle variables and Breslow thickness are shown (Table 1). Consistent with published data [1], increasing tumor thickness was significantly associated with presence of ulceration (p<0.001), higher mitotic indices (p<0.001), increasing Clark level (p<0.001), presence of microsatellitosis (p=0.017) and absence of regression (p=0.005), indicating that our sample is representative. We also observed an increase of nodular melanomas and a corresponding decrease in superficial spreading tumors among the thicker lesions (p<0.001). As this cohort was accrued prior to sentinel lymph node biopsy adoption [27], the presence and distribution of nodal micrometastases is not available. Breslow thickness was not associated with any demographic or lifestyle variable.

Table 1.

Characteristics of the study sample according to Breslow thickness

1.01–2.00 mm (N=123)
2.01–4.00 mm (N=83)
>4.00 mm (N=43)
N % N % N % P values
Demographic Parameters
Age at diagnosis
 65 years or less 83 67.5 53 63.9 22 51.2 0.160
 More than 65 years 40 32.5 30 36.1 21 48.8
Sex
 Male 66 53.7 46 55.4 29 67.4 0.281
 Female 57 46.3 37 44.6 14 32.6
Education level
 Some high school 18 14.6 14 16.9 11 25.6 0.100
 High school diploma 37 30.1 19 22.9 13 30.2
 Some college 22 17.9 29 34.9 8 18.6
 Bachelor’s degree 23 18.7 11 13.3 7 16.3
 Graduate degree 23 18.7 10 12.1 4 9.3
Marital status
 Married 89 72.4 61 73.5 29 67.4 0.898
 Separated/divorced 9 7.3 3 3.6 3 7.0
 Widowed 12 9.8 11 13.3 6 14.0
 Never married 13 10.6 8 9.6 5 11.6
Hair color
 Brown or black 73 59.4 50 60.2 23 53.4 0.177
 Blonde 33 26.8 14 16.9 14 32.6
 Red 17 13.8 19 22.9 6 14.0
Eye color
 Brown or black 26 21.1 15 18.1 8 18.6 0.847
 Blue or green 97 78.9 68 81.9 35 81.4
Pathologic Parameters
Ulceration <0.001
 Absent 111 90.2 50 60.2 19 44.2
 Present 12 9.8 33 39.8 24 55.8
Mitotic index
 0 mitoses/mm2 13 10.6 1 1.2 0 0.0 <0.001
 1–6 mitoses/mm2 92 74.8 33 39.8 19 44.2
 More than 6 mitoses/mm2 18 14.6 49 59.0 24 55.8
Clark level
 II–III 47 38.8 15 18.8 2 5.0 <0.001
 IV–V 74 61.2 65 81.3 38 95.0
Anatomic site
 Head and neck 13 10.9 15 18.8 5 11.9 0.594
 Trunk 70 58.8 36 45.0 22 52.4
 Upper extremities 17 14.3 14 17.5 7 16.7
 Lower extremities 19 16.0 15 18.8 8 19.1
Tumor-infiltrating lymphocytes
 None 57 46.3 41 49.4 20 47.6 0.327
 Non-brisk 48 39.0 37 44.6 19 45.2
 Brisk 18 14.6 5 6.0 3 7.1
Microsatellitosis
 Absent 116 94.3 70 92.1 31 79.5 0.017
 Present 7 5.7 6 7.9 8 20.5
Histologic subtype
 Superficial spreading 78 64.5 36 43.9 12 28.6 <0.001
 Nodular 11 9.1 23 28.1 17 40.5
 Lentigo maligna 14 11.6 7 8.5 4 9.5
 Other 18 14.9 16 19.5 9 21.4
Solar elastosis
 Absent 87 70.7 63 75.9 33 76.7 0.618
 Present 36 29.3 20 24.1 10 23.3
Regression
 Absent 61 49.6 58 71.6 27 65.9 0.005
 Present 62 50.4 23 28.4 14 34.2
Lifestyle Parameters
Body mass index
 Less than 25 kg/m2 58 47.2 36 43.4 13 31.0 0.081
 25–29.9 kg/m2 51 4.5 30 36.1 17 40.5
 30 kg/m2 or more 14 11.4 17 20.5 12 28.6
Tobacco use
 Never 50 42.0 31 38.8 13 31.7 0.078
 Former, ≤20 pack-years 23 19.3 18 22.5 4 9.8
 Former, >20 pack-years 29 24.4 22 27.5 10 24.4
 Current, ≤20 pack-years 9 7.6 3 3.8 5 12.2
 Current, >20 pack-years 8 6.7 6 7.5 9 22.0
Alcohol consumption
 Never 29 23.6 18 21.7 14 32.6 0.222
 Less than 1 drink/week 42 34.2 31 37.4 8 18.6
 1–5 drinks/week 33 26.8 21 25.3 9 20.9
 More than 5 drinks/week 19 15.5 13 15.7 12 27.9
Vitamin use
 None 61 49.6 43 51.8 21 48.8 0.934
 Any 62 50.4 40 48.2 22 51.2
Fruit consumption
 Less than daily 40 32.5 30 36.1 21 48.8 0.160
 Daily or more 83 67.5 53 63.9 22 51.2
Green salad consumption
 Less than weekly 23 18.7 16 19.3 13 30.2 0.252
 Weekly or more 100 81.3 67 80.7 30 69.8
Red meat consumption
 Less than weekly 33 26.8 22 26.5 10 23.3 0.895
 Weekly or more 90 73.2 61 73.5 33 76.7
Fish consumption
 Less than weekly 70 56.9 55 66.3 29 67.4 0.283
 Weekly or more 53 43.1 28 33.7 14 32.6
a

Rows may not sum to total due to missing values; percents may not sum to 100% due to rounding

Table 2 presents the individual crude and multivariable HRs for all demographic, lifestyle and pathologic variables, the latter adjusted for Breslow thickness, age, sex, ulceration and microsatellitosis – established prognostic factors in early-stage melanoma [28]. Of the 18 variables evaluated, only red meat consumption, hair color and anatomic site yielded significant independent multivariable-adjusted associations with melanoma survival. More frequent red meat consumption yielded poorer survival, (adjusted HR=1.93 (95% CI: 1.08–3.45); p=0.018). By contrast, either blonde (adjusted HR=0.63 (95% CI: 0.36–1.10)) or red hair (adjusted HR=0.50 (95% CI: 0.25–0.99)) conferred a survival advantage (overall p=0.048). Similarly, compared with the survival observed for head and neck melanomas, melanomas occurring on the trunk (adjusted HR=0.47 (95% CI: 0.26–0.84)), upper extremities (adjusted HR=0.37 (95% CI: 0.16–0.85)) or lower extremities (adjusted HR=0.29 (95% CI: 0.13–0.69)) demonstrated improved survival (overall p=0.018). More frequent fruit (adjusted HR=0.65 (95% CI: 0.42–1.02); p=0.06) and fish (adjusted HR=0.66 (95% CI: 0.41–1.06); p=0.08) consumption were of borderline statistical significance. We also observed that, following adjustment for clinicopathologic parameters, individuals who were current heavy smokers had borderline significant worse survival outcomes compared to the never-smoking reference group (adjusted HR=2.01 (95% CI: 0.99–4.07), Wald p=0.054). However as this group represented only a small portion of the study sample (n=23, 9.58%), the overall likelihood ratio p-value was not significant (overall p=0.251). A larger sample is required to characterize melanoma survival among current heavy smokers.

Table 2.

Crude and covariate-adjusteda melanoma-specific survival Cox regression model results for demographic, pathologic and lifestyle variables

Univariate
Hazard Ratio (95% CI)
P value Multivariablea
Hazard Ratio (95% CI)
P value
Demographic Parameters
Education level
 Some high school 1.00 0.332 1.00 0.630
 High school diploma 0.77 (0.42–1.41) 1.03 (0.51–2.08)
 Some college 0.55 (0.29–1.07) 0.71 (0.34–1.51)
 Bachelor’s degree 0.51 (0.24–1.07) 0.66 (0.27–1.61)
 Graduate degree 0.71 (0.36–1.42) 0.98 (0.44–2.17)
Marital status
 Married 1.00 0.327 1.00 0.475
 Separated/divorced 0.48 (0.15–1.53) 0.74 (0.23–2.39)
 Widowed 1.15 (0.60–2.25) 1.21 (0.59–2.47)
 Never married 1.39 (0.75–2.58) 1.75 (0.84–3.65)
Hair color
 Brown or black 1.00 0.012 1.00 0.048
 Blonde 0.72 (0.43–1.19) 0.63 (0.36–1.10)
 Red 0.57 (0.30–1.08) 0.50 (0.25–0.99)
Eye color
 Brown or black 1.00 0.298 1.00 0.634
 Blue or green 1.32 (0.77–2.26) 1.14 (0.65–2.03)
Pathologic Parameters
Mitotic index
 0 mitoses/mm2 1.00 0.054 1.00 0.991
 1–6 mitoses/mm2 1.78 (0.56–5.72) 1.09 (0.33–3.59)
 More than 6 mitoses/mm2 2.71 (0.84–8.77) 1.09 (0.31–3.85)
Anatomic Site
 Head and neck 1.00 0.020 1.00 0.018
 Trunk 0.52 (0.31–0.89) 0.47 (0.26–0.84)
 Upper extremities 0.41 (0.19–0.87) 0.37 (0.16–0.85)
 Lower extremities 0.33 (0.16–0.70) 0.29 (0.13–0.69)
Tumor-infiltrating lymphocytes
 None 1.00 0.051 1.00 0.111
 Non-brisk 0.94 (0.62–1.44) 0.93 (0.59–1.45)
 Brisk 0.34 (0.12–0.95) 0.38 (0.13–1.07)
Histologic subtype
 Superficial spreading 1.00 0.001 1.00 0.151
 Nodular 2.08 (1.21–3.57) 1.33 (0.73–2.44)
 Lentigo maligna 2.26 (1.11–4.60) 1.87 (0.88–4.01)
 Other 2.61 (1.54–4.41) 1.90 (1.04–3.48)
Solar elastosis
 Absent 1.00 0.520 1.00 0.749
 Present 1.17 (0.73–1.86) 1.09 (0.65–1.82)
Regression
 Absent 1.00 0.132 1.00 0.151
 Present 0.72 (0.47–1.11) 0.71 (0.44–1.14)
Lifestyle Parameters
Body mass index (BMI)
 Less than 25.0 kg/m2 1.00 0.931 1.00 0.554
 25.0–29.9 kg/m2 1.09 (0.70–1.70) 0.80 (0.49–1.33)
 30.0 kg/m2 or more 1.02 (0.56–1.84) 0.74 (0.40–1.37)
Tobacco use
 Never 1.00 0.104 1.00 0.251
 Former, ≤20 pack-years 0.90 (0.49–1.67) 0.85 (0.44–1.64)
 Former, >20 pack-years 1.04 (0.59–1.81) 0.90 (0.49–1.64)
 Current, ≤20 pack-years 1.29 (0.59–2.80) 1.41 (0.62–3.21)
 Current, >20 pack-years 2.31 (1.25–4.27) 2.01 (0.99–4.07)
Alcohol consumption
 Never 1.00 0.202 1.00 0.327
 Less than 1 drink/week 0.64 (0.36–1.14) 0.59 (0.32–1.10)
 1–5 drinks/week 0.94 (0.54–1.65) 0.93 (0.51–1.70)
 More than 5 drinks/week 1.18 (0.65–2.15) 0.90 (0.47–1.73)
Vitamin use at diagnosis
 None 1.00 0.997 1.00 0.989
 Any 1.00 (0.66–1.50) 1.00 (0.65–1.55)
Fruit consumption at diagnosis
 Less than daily 1.00 0.062 1.00 0.074
 At least daily 0.67 (0.45–1.02) 0.66 (0.42–1.04)
Green salad consumption at diagnosis
 Less than weekly 1.00 0.485 1.00 0.583
 Weekly or more 0.84 (0.52–1.37) 0.87 (0.52–1.44)
Red meat consumption at diagnosis
 Less than weekly 1.00 0.008 1.00 0.018
 Weekly or more 1.97 (1.15–3.38) 1.93 (1.08–3.45)
Fish consumption at diagnosis
 Less than weekly 1.00 0.100 1.00 0.072
 Weekly or more 0.70 (0.45–1.08) 0.65 (0.40–1.05)
a

Adjusted for Breslow thickness, age at diagnosis, sex, ulceration and microsatellitosis

To assess combined effects, we included each of the variables independently that had an adjusted p-value <0.10 into a single multivariable model that also included the 5 baseline clinicopathologic covariates and conducted backwards elimination until all retained covariates were significant at p<0.05. As all non-head and neck anatomic sites conferred a similar survival advantage, this variable was dichotomized accordingly. Fruit consumption, red meat consumption, hair color and anatomic site each remained significant following adjustment for age at diagnosis and Breslow thickness (Table 3).

Table 3.

Combined multivariable Cox models for the independently-significant lifestyle factors, adjusting for clinicopathologic covariates

Multivariate HR (95% CI) P value
Age at diagnosis
 65 years or less 1.00 0.012
 Greater than 65 years 1.86 (1.16–3.01)
Breslow thickness
 1.01–2.00 mm 1.00 0.003
 2.01–4.00 mm 1.65 (0.97–2.81)
 4.01 mm or more 2.81 (1.58–4.99)
Anatomic location
 Head and neck 1.00 0.002
 Trunk or limbs 0.39 (0.22–0.68)
Hair color
 Brown or black 1.00 0.009
 Blonde 0.52 (0.29–0.94)
 Red 0.44 (0.22–0.88)
Fruit consumption at diagnosis
 Less than daily 1.00 0.010
 At least daily 0.54 (0.34–0.86)
Red meat consumption at diagnosis
 Less than weekly 1.00 0.030
 Weekly or more 1.84 (1.02–3.30)

4. Discussion

Although 30%–70% of patients with intermediate-thickness or thick localized melanomas will die of their disease despite complete resection, active surveillance is standard for the majority of these patients. Consequently, melanoma survivors would be interested in pursuing lifestyle choices with the potential to reduce their risk of recurrence. Melanoma survivors already reduce overall UV exposure to prevent second primary melanomas [2931]. Yet, data regarding the association between other modifiable lifestyle behaviors and melanoma survival is sparse and encouraging their modification in melanoma survivorship clinics is premature. Here, we evaluated the survival benefit of BMI, smoking, alcohol use and dietary preferences as recorded at the time of diagnosis to identify the subset associated with improved melanoma-specific survival.

In our final model that adjusted for age, Breslow thickness, anatomic location of the primary tumor, hair color and fruit consumption, significantly poorer outcomes were observed among individuals who consumed red meat once or more per week. Red meat consumption is prognostic for colorectal cancer where higher consumption before and after diagnosis are associated with increased disease-specific mortality [32, 33]. Here, putative mechanisms include direct exposure of the colorectal mucosa to fatty acid [34] or heme iron [35]-induced oxidative damage, inflammation and vascular dysfunction [36] and chromosomal damage from polyaromatic hydrocarbons and heterocyclic amines generated during processing and cooking [37, 38]. Consumption of extensively grilled, but not rare, red meat was also associated with increased risk of aggressive prostate cancer [38], supporting the relevance of red meat-associated exposures for target organs outside the gastrointestinal tract. As melanoma evasion of the host immune system contributes to metastatic progression, recent research describing metabolic reprogramming of the immune system posits a complementary hypothesis. One mechanism promoting immune evasion is a relative excess of CD4+ regulatory T lymphocytes (Treg) within the TIL population [39]. Tumor microenvironments rich in free fatty acids, via signal transduction through the phosphatidyl-inositol-3-kinase/mTOR cascade, promote the differentiation of naïve T-cells into Treg subpopulations [40]. As regular consumption of red meat correlates with elevated serum triglyceride levels [41], it is possible that diets high in red meat can trigger an immunosuppressive Treg excess. Validation in appropriate model systems is required.

Following similar multivariable adjustment, we also report improved survival with daily fruit consumption at the time of diagnosis. Five or more daily fruit servings have been shown to decrease the risk for diverse chronic diseases including cardiovascular diseases, cancer, dementia, osteoporosis and rheumatoid arthritis [42, 43] with pharmacodynamic studies of whole-fruit extracts [44, 45] or of specific components including resveratrol [46] and lycopene [47] supporting increased intake of anti-oxidative phytochemicals as the underlying mechanism. Nonetheless, the impact of fruit consumption on cancer-specific survival is still emerging. While a statistically-significant inverse association between overall survival and increased fruit consumption was observed among women enrolled in the US-based Multi-Ethnic Cohort (MEC) study (HR for more than 4.8 servings/day=0.82; 95% CI: 0.69–0.92), null results were obtained in both the European Prospective Investigation into Cancer and Nutrition (EPIC) study (HR=0.96; 95% CI: 0.90–1.03) and among MEC men (HR=0.96; 95% CI: 0.84–1.09) [48, 49]. Both these studies, however, enrolled healthy individuals who were cancer-free at the time of their dietary assessment compared to our population who had already received their cancer diagnosis at the time of study enrollment and interview. Moreover, as breakdown by cancer subtypes was not done in either study, melanoma-specific survival could not be evaluated.

The remaining lifestyle variables were not associated with melanoma survival. Our data for BMI are consistent with the two large studies previously reporting null associations with melanoma-specific survival [20, 21]. For smoking, while we observed significantly worse survival among current heavy smokers, this group contained few individuals and the overall effect of our smoking variable was null consistent with the null results reported by Warren et al. [9]. Although our data are discordant with the protective effects of smoking noted in CPS-II, the lack of dose-response across pack-years in that study questions the validity of that result [22].

Among clinicopathologic variables, we observed improved survival among individuals with red or blonde hair. Our findings on the survival benefit associated with red and blonde hair color is consistent with the survival benefit observed among individuals who carry blond or red hair-conferring melanocortin-1 receptor variants [50]. We also noted worse outcomes for head and neck melanomas, consistent with prior reports [51].

Our study notes several strengths. We are the first to consider the association of dietary factors with melanoma outcomes. Next, we restricted our cohort to individuals with advanced localized disease who have the most to benefit from non-therapeutic treatment alternatives. We also recognize several important weaknesses in our study. First, our measurement of lifestyle behaviors was based upon a single measurement taken at the time of diagnosis which carries the now-proven false assumption that subjects maintain their pre-diagnostic behaviors throughout the follow-up period [52], creating nondifferential misclassification of lifestyle exposures and bias towards the null. Additionally, for post-diagnosis behavior changes that would be predicated on the pre-diagnosis behavior (e.g., rates of smoking cessation among current smokers versus new-onset smoking among never-smokers), differential misclassification can occur. Validation of all our results in prospective longitudinal studies with repeated post-diagnosis lifestyle measurements is necessary. Next, due to our small sample size we cannot rule out false negative results. We did not detect an association with green salad, a dietary choice equally rich in phytochemicals, and our trend towards significance for fish consumption disappeared when included in a multivariable model with fruit. Third, as “daily” was the highest consumption level coded for fruit intake, we could not further refine our analysis discriminate among individuals with at least daily fruit consumption those who adhered to the “5-a-day” recommendations [43, 52] from those who did not. Lastly, our food group categories and their semi-quantitative measurements did not support reclassification into dietary subtypes, the preferred method for analyzing food-based exposures as they not only parallel the 2010 Dietary Guidelines for Americans [53] but they also account for the strong correlations between certain individual food choices, acknowledging that the effect size for single dietary constituents might be too small to measure [54].

In conclusion, we report significant associations between red meat or fruit consumption at the time of diagnosis with melanoma-specific survival, in patients with localized melanomas more than 1.00 mm thick, a group where recurrence following curative resection is not uncommon but in whom active surveillance is standard. Further validation of our findings is warranted to further evaluate whether their modification during the survivorship period can improve melanoma-specific survival. We not only propose examining patterns of red meat and fruit consumption in larger cohorts of Stage II patients where repeated post-diagnostic measures are captured but also promote exploring their relevance to the survival from Stage I melanomas, a population subset that includes over 70% of newly-diagnosed cases but where the observed 10-year melanoma-specific survival exceeds 90% [55].

HIGHLIGHTS.

  • 249 patients with localized melanomas ≥1.00 mm thick were followed for 15 years.

  • Smoking, dietary preferences, BMI and alcohol use were measured at diagnosis.

  • After adjustment for tumor thickness, age, lesion location and hair color:
    • Eating red meat at least weekly was associated with poorer survival.
    • Eating fruit at least daily was associated with better survival.

Acknowledgments

We thank the following institutions for their part in the collection of the data for the Connecticut Skin Self-Examination Case-Control Study (parent study): University of Connecticut Dermatopathology Laboratory; Farmington, CT; Connecticut Dermatopathology Laboratory, Inc., Torrington, CT; Laboratory of Hope-Ross and Portnoy, Bridgeport, CT; Yale Dermatopathology Laboratory, New Haven, CT; Hartford Hospital, Hartford, CT; Yale-New Haven Hospital, New Haven, CT; St. Francis Hospital and Medical Center, Hartford, CT; Bridgeport Hospital, Bridgeport, CT; Waterbury Hospital, Waterbury, CT; Hospital of St. Raphael, New Haven, CT; Danbury Hospital, Danbury, CT; New Britain General Hospital, New Britain, CT; Norwalk Hospital, Norwalk, CT; St. Vincent’s Medical Center, Bridgeport, CT; The Stamford Hospital, Stamford, CT; Middlesex Hospital, Middletown, CT; Mt. Sinai Hospital; Hartford, CT; St. Mary’s Hospital, Waterbury, CT; Lawrence & Memorial Hospital, New London, CT; Manchester Hospital, Manchester, CT; Greenwich Hospital Association, Greenwich, CT; Mid-State Medical Center, Meriden, CT; Griffin Hospital, Derby, CT; Bristol Hospital, Bristol, CT; St. Joseph Medical Center, Stamford, CT; UConn Health Center/John Dempsey Hospital, Farmington, CT; William W. Backus Hospital, Norwich, CT; Park City Hospital, Bridgeport, CT; Charlotte Hungerford Hospital, Torrington, CT; Windham Memorial Hospital, Willimantic, CT; Milford Hospital, Milford, CT; Day Kimball Hospital, Putnam, CT; Rockville General Hospital, Rockville, CT; Bradley Memorial Hospital, Southington, CT; The Sharon Hospital, Sharon, CT; New Milford Hospital, New Milford, CT; Johnson Memorial Hospital, Stafford Springs, CT; Winsted Hospital, Winsted, CT; and Westerly Hospital, Westerly, RI.

Financial support: US National Cancer Institute Grant K08 CA151645 to Bonnie E. Gould Rothberg (to conduct the submitted secondary analysis)

US National Cancer Institute Grant P01 CA42101 to Cancer Prevention Research Unit at Yale University (Marianne Berwick to conduct the parent study)

The sponsor has had no role for the conduct of the research or preparation of this article.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Submission Declaration: This article has not been published previously and is not under consideration for publication elsewhere.

Conflict of Interest Statement: None of the listed authors have actual, potential or perceived conflicts of interest with the data presented in the manuscript.

Contributor Information

Bonnie E. Gould Rothberg, Email: bonnie.gouldrothberg@yale.edu.

Kaleigh J. Bulloch, Email: Kaleigh.bulloch@yale.edu.

Judith A. Fine, Email: judie7168@gmail.com.

Raymond L. Barnhill, Email: rbarnhill@mednet.ucla.edu.

Marianne Berwick, Email: mberwick@salud.unm.edu.

References

  • 1.Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–206. doi: 10.1200/JCO.2009.23.4799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Petrella T, Verma S, Spithoff K, Quirt I, McCready D. Adjuvant interferon therapy for patients at high risk for recurrent melanoma: an updated systematic review and practice guideline. Clinical Oncology. 2012 doi: 10.1016/j.clon.2011.12.002. [DOI] [PubMed] [Google Scholar]
  • 3.Psychological challenges of surviving cancer. Transitions are particularly tough; some problems emerge at unexpected times. Harv Ment Health Lett. 2008;25:4–5. [PubMed] [Google Scholar]
  • 4.Kasparian NA. Psychological care for people with melanoma: what, when, why and how? Semin Oncol Nurs. 2013;29:214–22. doi: 10.1016/j.soncn.2013.06.007. [DOI] [PubMed] [Google Scholar]
  • 5.Atkinson TM, Noce NS, Hay J, Rafferty BT, Brady MS. Illness-related distress in women with clinically localized cutaneous melanoma. Ann Surg Oncol. 2013;20:675–9. doi: 10.1245/s10434-012-2635-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Holterhues C, Cornish D, van de Poll-Franse LV, Krekels G, Koedijk F, Kuijpers D, et al. Impact of melanoma on patients’ lives among 562 survivors: a Dutch population-based study. Arch Dermatol. 2011;147:177–85. doi: 10.1001/archdermatol.2010.433. [DOI] [PubMed] [Google Scholar]
  • 7.Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol. 2005;23:5814–30. doi: 10.1200/JCO.2005.01.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. Bmj. 2010;340:b5569. doi: 10.1136/bmj.b5569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Warren GW, Kasza KA, Reid ME, Cummings KM, Marshall JR. Smoking at diagnosis and survival in cancer patients. Int J Cancer. 2013;132:401–10. doi: 10.1002/ijc.27617. [DOI] [PubMed] [Google Scholar]
  • 10.Warnakulasuriya S. Living with oral cancer: epidemiology with particular reference to prevalence and lifestyle changes that influence survival. Oral Oncol. 2010;46:407–10. doi: 10.1016/j.oraloncology.2010.02.015. [DOI] [PubMed] [Google Scholar]
  • 11.Mayne ST, Cartmel B, Kirsh V, Goodwin WJ., Jr Alcohol and tobacco use prediagnosis and postdiagnosis, and survival in a cohort of patients with early stage cancers of the oral cavity, pharynx, and larynx. Cancer Epidemiol Biomarkers Prev. 2009;18:3368–74. doi: 10.1158/1055-9965.EPI-09-0944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Davies NJ, Batehup L, Thomas R. The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature. Br J Cancer. 2011;105(Suppl 1):S52–73. doi: 10.1038/bjc.2011.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.George SM, Irwin ML, Smith AW, Neuhouser ML, Reedy J, McTiernan A, et al. Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer. Cancer Causes Control. 2011;22:589–98. doi: 10.1007/s10552-011-9732-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Irwin ML, McTiernan A, Manson JE, Thomson CA, Sternfeld B, Stefanick ML, et al. Physical activity and survival in postmenopausal women with breast cancer: results from the women’s health initiative. Cancer Prev Res (Phila) 2011;4:522–9. doi: 10.1158/1940-6207.CAPR-10-0295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Meyerhardt JA, Ma J, Courneya KS. Energetics in colorectal and prostate cancer. J Clin Oncol. 2010;28:4066–73. doi: 10.1200/JCO.2009.26.8797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Branstrom R, Chang YM, Kasparian N, Affleck P, Tibben A, Aspinwall LG, et al. Melanoma risk factors, perceived threat and intentional tanning: an international online survey. Eur J Cancer Prev. 2010;19:216–26. doi: 10.1097/CEJ.0b013e3283354847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Mujumdar UJ, Hay JL, Monroe-Hinds YC, Hummer AJ, Begg CB, Wilcox HB, et al. Sun protection and skin self-examination in melanoma survivors. Psycho-oncology. 2009;18:1106–15. doi: 10.1002/pon.1510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Oliveria SA, Hay JL, Geller AC, Heneghan MK, McCabe MS, Halpern AC. Melanoma survivorship: research opportunities. J Cancer Surviv. 2007;1:87–97. doi: 10.1007/s11764-007-0009-y. [DOI] [PubMed] [Google Scholar]
  • 19.Soto E, Lee H, Saladi RN, Gerson Y, Manginani S, Lam K, et al. Behavioral factors of patients before and after diagnosis with melanoma: a cohort study – are sun-protection measures being implemented? Melanoma Res. 2010;20:147–52. doi: 10.1097/CMR.0b013e328328f802. [DOI] [PubMed] [Google Scholar]
  • 20.Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38. doi: 10.1056/NEJMoa021423. [DOI] [PubMed] [Google Scholar]
  • 21.Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. Bmj. 2007;335:1134. doi: 10.1136/bmj.39367.495995.AE. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.DeLancey JO, Hannan LM, Gapstur SM, Thun MJ. Cigarette smoking and the risk of incident and fatal melanoma in a large prospective cohort study. Cancer Causes Control. 2011;22:937–42. doi: 10.1007/s10552-011-9766-z. [DOI] [PubMed] [Google Scholar]
  • 23.Chen YT, Dubrow R, Zheng T, Barnhill RL, Fine J, Berwick M. Sunlamp use and the risk of cutaneous malignant melanoma: a population-based case-control study in Connecticut, USA. Int J Epidemiol. 1998;27:758–65. doi: 10.1093/ije/27.5.758. [DOI] [PubMed] [Google Scholar]
  • 24.Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL. Screening for cutaneous melanoma by skin self-examination. Journal of the National Cancer Institute. 1996;88:17–23. doi: 10.1093/jnci/88.1.17. [DOI] [PubMed] [Google Scholar]
  • 25.Chen YT, Dubrow R, Holford TR, Zheng T, Barnhill RL, Fine J, et al. Malignant melanoma risk factors by anatomic site: a case-control study and polychotomous logistic regression analysis. Int J Cancer. 1996;67:636–43. doi: 10.1002/(SICI)1097-0215(19960904)67:5<636::AID-IJC8>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  • 26.Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. Jama. 2012;307:491–7. doi: 10.1001/jama.2012.39. [DOI] [PubMed] [Google Scholar]
  • 27.Bagaria SP, Faries MB, Morton DL. Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute. J Surg Oncol. 2010;101:669–76. doi: 10.1002/jso.21581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622–34. doi: 10.1200/JCO.2001.19.16.3622. [DOI] [PubMed] [Google Scholar]
  • 29.Oliveria SA, Shuk E, Hay JL, Heneghan M, Goulart JM, Panageas K, et al. Melanoma survivors: health behaviors, surveillance, psychosocial factors, and family concerns. Psycho-oncology. 2013;22:106–16. doi: 10.1002/pon.2059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Bowen D, Jabson J, Haddock N, Hay J, Edwards K. Skin care behaviors among melanoma survivors. Psycho-oncology. 2012;21:1285–91. doi: 10.1002/pon.2017. [DOI] [PubMed] [Google Scholar]
  • 31.Lee TK, Brazier AS, Shoveller JA, Gallagher RP. Sun-related behavior after a diagnosis of cutaneous malignant melanoma. Melanoma Res. 2007;17:51–5. doi: 10.1097/CMR.0b013e3280112b98. [DOI] [PubMed] [Google Scholar]
  • 32.McCullough ML, Gapstur SM, Shah R, Jacobs EJ, Campbell PT. Association between red and processed meat intake and mortality among colorectal cancer survivors. J Clin Oncol. 2013;31:2773–82. doi: 10.1200/JCO.2013.49.1126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Vrieling A, Kampman E. The role of body mass index, physical activity, and diet in colorectal cancer recurrence and survival: a review of the literature. Am J Clin Nutr. 2010;92:471–90. doi: 10.3945/ajcn.2010.29005. [DOI] [PubMed] [Google Scholar]
  • 34.Speed N, Blair IA. Cyclooxygenase- and lipoxygenase-mediated DNA damage. Cancer Metastasis Rev. 2011;30:437–47. doi: 10.1007/s10555-011-9298-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Fonseca-Nunes A, Jakszyn P, Agudo A. Iron and Cancer Risk–A Systematic Review and Meta-analysis of the Epidemiological Evidence. Cancer Epidemiol Biomarkers Prev. 2014;23:12–31. doi: 10.1158/1055-9965.EPI-13-0733. [DOI] [PubMed] [Google Scholar]
  • 36.Fung TT, McCullough ML, Newby PK, Manson JE, Meigs JB, Rifai N, et al. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr. 2005;82:163–73. doi: 10.1093/ajcn.82.1.163. [DOI] [PubMed] [Google Scholar]
  • 37.Sugimura T. Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process. Mutat Res. 1985;150:33–41. doi: 10.1016/0027-5107(85)90098-3. [DOI] [PubMed] [Google Scholar]
  • 38.Punnen S, Hardin J, Cheng I, Klein EA, Witte JS. Impact of meat consumption, preparation, and mutagens on aggressive prostate cancer. PLoS One. 2011;6:e27711. doi: 10.1371/journal.pone.0027711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Jacobs JF, Nierkens S, Figdor CG, de Vries IJ, Adema GJ. Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy? Lancet Oncol. 2012;13:e32–42. doi: 10.1016/S1470-2045(11)70155-3. [DOI] [PubMed] [Google Scholar]
  • 40.Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ, Mason EF, et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol. 2011;186:3299–303. doi: 10.4049/jimmunol.1003613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Azadbakht L, Esmaillzadeh A. Red meat intake is associated with metabolic syndrome and the plasma C-reactive protein concentration in women. J Nutr. 2009;139:335–9. doi: 10.3945/jn.108.096297. [DOI] [PubMed] [Google Scholar]
  • 42.Hung HC, Joshipura KJ, Jiang R, Hu FB, Hunter D, Smith-Warner SA, et al. Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst. 2004;96:1577–84. doi: 10.1093/jnci/djh296. [DOI] [PubMed] [Google Scholar]
  • 43.Boeing H, Bechthold A, Bub A, Ellinger S, Haller D, Kroke A, et al. Critical review: vegetables and fruit in the prevention of chronic diseases. Eur J Nutr. 2012;51:637–63. doi: 10.1007/s00394-012-0380-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.God J, Tate PL, Larcom LL. Red raspberries have antioxidant effects that play a minor role in the killing of stomach and colon cancer cells. Nutr Res. 2010;30:777–82. doi: 10.1016/j.nutres.2010.10.004. [DOI] [PubMed] [Google Scholar]
  • 45.Ribeiro FA, Gomes de Moura CF, Aguiar O, Jr, de Oliveira F, Spadari RC, Oliveira NR, et al. The chemopreventive activity of apple against carcinogenesis: antioxidant activity and cell cycle control. Eur J Cancer Prev. 2013 doi: 10.1097/CEJ.0000000000000005. [DOI] [PubMed] [Google Scholar]
  • 46.Chung MY, Lim TG, Lee KW. Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development. World J Gastroenterol. 2013;19:984–93. doi: 10.3748/wjg.v19.i7.984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Sharoni Y, Linnewiel-Hermoni K, Zango G, Khanin M, Salman H, Veprik A, et al. The role of lycopene and its derivatives in the regulation of transcription systems: implications for cancer prevention. Am J Clin Nutr. 2012;96:1173S–8S. doi: 10.3945/ajcn.112.034645. [DOI] [PubMed] [Google Scholar]
  • 48.Leenders M, Sluijs I, Ros MM, Boshuizen HC, Siersema PD, Ferrari P, et al. Fruit and vegetable consumption and mortality: European prospective investigation into cancer and nutrition. Am J Epidemiol. 2013;178:590–602. doi: 10.1093/aje/kwt006. [DOI] [PubMed] [Google Scholar]
  • 49.Sharma S, Vik S, Pakseresht M, Shen L, Kolonel LN. Diet impacts mortality from cancer: results from the multiethnic cohort study. Cancer Causes Control. 2013;24:685–93. doi: 10.1007/s10552-013-0148-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Davies JR, Randerson Moor J, Kukalizch K, Harland M, Kumar R, Madhusudan S, et al. Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study. Pigment cell & melanoma research. 2012 doi: 10.1111/j.1755-148X.2012.00982.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Fadaki N, Li R, Parrett B, Sanders G, Thummala S, Martineau L, et al. Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome? Ann Surg Oncol. 2013;20:3089–97. doi: 10.1245/s10434-013-2977-7. [DOI] [PubMed] [Google Scholar]
  • 52.Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA: a cancer journal for clinicians. 2012;62:243–74. doi: 10.3322/caac.21142. [DOI] [PubMed] [Google Scholar]
  • 53.US Department of Agriculture and US Department of Health and Human Services. Dietary Guidelines for Americans, 2010. Washington, DC: US Government Printing Office; 2010. [Google Scholar]
  • 54.Bosire C, Stampfer MJ, Subar AF, Park Y, Kirkpatrick SI, Chiuve SE, et al. Index-based dietary patterns and the risk of prostate cancer in the NIH-AARP diet and health study. Am J Epidemiol. 2013;177:504–13. doi: 10.1093/aje/kws261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Gimotty PA, Guerry D. Prognostication in thin cutaneous melanomas. Arch Pathol Lab Med. 2010;134:1758–63. doi: 10.5858/2009-0653-RAR.1. [DOI] [PubMed] [Google Scholar]

RESOURCES